The preset invention relates to a biomarker for identifying the subgroup of {HEAD ~ early stage lung adenocarcinoma patients} in early stage non small cell lung cancer , which is T lymphokine activated killer cell originated protein kinase , and a therapeutic target for {TAIL ~ lung cancer} 
The preset invention relates to a biomarker for identifying the subgroup of { HEAD ~ early stage lung adenocarcinoma patients } in early stage non small cell lung cancer , which is T lymphokine activated killer cell originated protein kinase , and a therapeutic target for { TAIL ~ lung cancer }
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL